Chemours, EPA 'behind our backs' deal heavily criticized in North Carolina. (The Center Square) - Two elected executive officers for North Carolina, and a member of the Stein administration, oppose the proposed settlement negotiated they say "behind our backs" by the EPA and Chemours. First-term Democratic Gov. Josh Stein, first-term Democratic Attorney General Jeff Jackson and Secretary Reid Wilson of the Division of Environmental Quality made their case to the U.S. assistant attorney general's office. Penalties for Wilmington, Del.-headquartered Chemours in the $450 million settlement are $22.5 million in civil penalties and implementation of injunctive relief programs. Additionally, Chemours will conduct a multi-year, $90 million program to mitigate PFAS discharges; install PFAS pollution controls for surface water discharges and air emissions at its facility in West Virginia, at an estimated cost of $60 million; supply clean drinking water for more than a decade to communities that surround its facilities in West Virginia and New Jersey at an estimated cost of $280 million; and evaluate options and implement corresponding controls to reduce releases of PFAS and other toxic chemicals from its facility in North Carolina. "Chemours and the EPA negotiated this deal behind our backs," Jackson said. "It does nothing to fix the decades of damage Chemours has done to our state, and it's offensive to the people who drink this water. That's why I'm asking the federal government to throw it out. The people of eastern North Carolina deserve better." The U.S. Department of Justice, Environmental Protection Agency, and West Virginia Department of Environmental Protection announced the deal June 24. The litigation concerns forever chemicals known as PFAS. PFAS, an acronym for per- and polyfluoroalkyl substances, are widely used, long-lasting chemicals whose components break down very slowly over time. Studies vary on their harmful effects; more is known about their impact on animals than on humans. PFAS, the Environmental Protection Agency says, "are found in water, air, fish, and soil at locations across the nation" and throughout the world. Chemours has a 6.7% market share in the global chemical sector, with $1.6 billion in liquidity per the U.S. Securities and Exchange Commission. Net sales in fiscal year 2025 were $5.8 billion, and standard earnings before interest, taxes, depreciation, and amortization - EBITDA - was $742 million. DuPont previously was the parent company of Chemours. "For decades, Chemours knowingly contaminated North Carolina's air and water by discharging PFAS from its Fayetteville plant into the Cape Fear River," Stein said. "Now, the EPA is cutting a deal with Chemours that does next to nothing for North Carolinians and allows polluters to choose what to clean up and where. I will continue to fight for North Carolinians' clean air and clean water." The trio of letter-writers say the deal should be withdrawn because EPA guidelines call for the state to be included in negotiations; the state received no drinking water relief; none of the $90 million for PFAS pollution reduction and alternative drinking water projects is required to be in North Carolina; and the state Department of Environmental Quality's demand Chemours install technology to reduce certain GenX pollution at 99.99% efficiency is greater than the EPA's 99.5% requirement, and those reductions can be claimed in other states and are not guaranteed to happen in North Carolina. They also say 200 or more Clean Water Act violations at Fayetteville Works are resolved "for no real benefit to North Carolina." The settlement addressed complaints linked to the federal Clean Water Act, Resource Conservation and Recovery Act, and Toxic Substance Control Act, along with West Virginia's Water Pollution Control Act. Chemours can "continue manufacturing PFAS for critical commercial and military applications while preventing future contamination and protecting communities from that contamination," a release from the Justice Department says. The complaint says Chemours discharged PFAS into the Ohio River, Cape Fear River and Delaware River in violation of government permits. Chemours also was accused of noncompliance with legal requirements under the Toxic Substances Control Act at all four targeted facilities. The North Carolina Supreme Court will hear oral arguments in September in Jackson's separate lawsuit against DuPont and Chemours. The StarNews newspaper in Wilmington was first to report contamination found in the Cape Fear River by N.C. State researchers in June 2017. It led to multiple litigations, the building of a $100 million thermal oxidizer designed to reduce air emissions at the riverside plant, testing, hearings and lots of finger-pointing for blame. At the time of discovery, the impact of GenX - a PFAS used to make nonstick coatings, for example, on cookware - and other PFAS on humans was evolving. Animal tests had indicated cancer possibilities, and humans were believed to be at risk for kidney or testicular cancer, elevated cholesterol levels and health challenges for children. Downstream from Chemours at the Fayetteville Works Plant, the Cape Fear River is a source of drinking water for about 1 million people in the region of a state with a population of 10.8 million. Locations. Currently in Dothan Rain Shower

Chemours (CC) to post earnings on Tuesday. July 28, 2026 Key points. * Chemours is expected to report Q2 2026 results after Tuesday's market close, with analysts forecasting earnings of $0.4964 per share and revenue of $1.6545 billion. The earnings call is scheduled for Wednesday, August 5, at 8:00 a.m. ET. * In its previous quarter, Chemours reported $0.05 in earnings per share, beating estimates, while revenue increased 1% year over year to $1.38 billion but fell short of expectations. * The stock recently traded at $16.86, well below its 52-week high of $28.67. Analysts maintain a "Moderate Buy" consensus rating with an average price target of $24.10, and the company pays an annualized dividend of $0.35 per share. * MarketBeat previews the top five stocks to own by August 1st. Chemours (NYSE:CC - Get Free Report) is projected to announce its Q2 2026 results after the market closes on Tuesday, August 4th. Analysts expect the company to post earnings of $0.4964 per share and revenue of $1.6545 billion for the quarter. Parties may review the information on the company's upcoming Q2 2026 earning report page for the latest details on the call scheduled for Wednesday, August 5, 2026 at 8:00 AM ET. Chemours (NYSE:CC - Get Free Report) last posted its quarterly earnings data on Tuesday, May 5th. The specialty chemicals company reported $0.05 earnings per share for the quarter, topping the consensus estimate of ($0.05) by $0.10. Chemours had a negative net margin of 6.82% and a positive return on equity of 52.49%. The company had revenue of $1.38 billion during the quarter, compared to analyst estimates of $1.40 billion. During the same quarter last year, the business posted $0.13 earnings per share. The company's revenue was up 1.0% on a year-over-year basis. On average, analysts expect Chemours to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year. Chemours price performance. Shares of NYSE:CC traded down $0.12 during trading on Tuesday, reaching $16.86. The stock had a trading volume of 176,321 shares, compared to its average volume of 3,043,907. Chemours has a 52 week low of $10.44 and a 52 week high of $28.67. The business's 50-day moving average price is $20.23 and its 200 day moving average price is $19.95. The company has a debt-to-equity ratio of 18.98, a current ratio of 1.82 and a quick ratio of 0.87. The stock has a market capitalization of $2.54 billion, a PE ratio of -6.38 and a beta of 1.41. Chemours announces dividend. The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 16th. Investors of record on Sunday, May 17th were issued a dividend of $0.0875 per share. This represents a $0.35 dividend on an annualized basis and a yield of 2.1%. The ex-dividend date of this dividend was Friday, May 15th. Chemours's dividend payout ratio (DPR) is currently -13.26%. Analyst ratings changes. A number of equities analysts have commented on the company. Zacks Research raised Chemours from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, July 21st. Mizuho dropped their target price on Chemours from $30.00 to $25.00 and set an "outperform" rating for the company in a research report on Wednesday, July 1st. Morgan Stanley upped their price target on Chemours from $17.00 to $21.00 and gave the company an "equal weight" rating in a research note on Monday, May 11th. JPMorgan Chase & Co. raised their price objective on shares of Chemours from $17.00 to $22.00 and gave the company a "neutral" rating in a research note on Thursday, May 21st. Finally, UBS Group increased their price objective on shares of Chemours from $29.00 to $30.00 and gave the stock a "buy" rating in a research note on Friday, May 8th. One equities research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $24.10. Discover more Market Cap Calculator Stock Screener Tool Hedge funds weigh in on Chemours. Several large investors have recently modified their holdings of CC. Baird Financial Group Inc. bought a new position in shares of Chemours in the first quarter worth $148,000. Royal Bank of Canada boosted its position in shares of Chemours by 6.8% during the 1st quarter. Royal Bank of Canada now owns 585,702 shares of the specialty chemicals company's stock valued at $7,926,000 after acquiring an additional 37,382 shares during the last quarter. AQR Capital Management LLC bought a new position in shares of Chemours in the first quarter worth approximately $161,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in Chemours by 149.3% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 43,243 shares of the specialty chemicals company's stock valued at $593,000 after purchasing an additional 25,899 shares in the last quarter. Finally, Empowered Funds LLC bought a new stake in Chemours during the first quarter valued at approximately $403,000. Hedge funds and other institutional investors own 76.26% of the company's stock. About Chemours. Chemours Company, established in 2015 as a spin-off from E. I. du Pont de Nemours and Company, is a global chemistry organization headquartered in Wilmington, Delaware. Since its formation, Chemours has focused on delivering performance chemicals that help customers lower their carbon footprint, increase energy efficiency and conserve water. The company operates with a commitment to safety, environmental stewardship and innovation. Chemours' principal business activities are organized into three core segments. This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected]. Before you consider Chemours, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemours wasn't on the list. While Chemours currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys. The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you'll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

PFAS "forever chemicals" Pollution sparks lawsuits: New York State sues 3M, DuPont, Chemours, and other chemical giants. 2026-07-20 09:31:12 Source:ChemNet 中文 On July 9, local time, New York State Attorney General Letitia James formally filed a lawsuit in the Albany State Court, naming 3M, DuPont, Chemours, Corteva, and EIDP as defendants, accusing the companies of long-term sales of consumer products containing per- and polyfluoroalkyl substances (PFAS), causing sustained environmental pollution in New York State and posing multiple threats to residents' health. The core focus of this lawsuit is directly on PFAS, known as "forever chemicals." Since their industrial development in the 1940s, these synthetic chemicals have been widely used in hundreds of daily and industrial products, such as non-stick cookware, waterproof clothing, food packaging, cosmetics, and industrial firefighting foam, due to their properties of water and oil resistance, high-temperature tolerance, and stain resistance. Because of their stable molecular structure, PFAS are extremely difficult to naturally degrade in soil, water sources, and organisms. They can accumulate and spread continuously over time, with pollution covering water bodies, soil, air, and the food chain. The New York State prosecution disclosed that numerous medical studies have confirmed that long-term exposure to specific PFAS substances significantly increases the risk of disease in humans. Associated health issues include various cancers, birth defects, pregnancy complications, high cholesterol, endocrine disruption, and thyroid damage. The complaint alleges that the involved companies long knew about the toxicity, environmental persistence, and bioaccumulation hazards of PFAS. However, through false and misleading advertising, they labeled toxic products as safe and harmless, deliberately concealed health and environmental risks, and illegally profited from non-compliant products for a long time, allegedly violating New York State consumer protection regulations. The Attorney General's Office stated in a declaration that over the past few decades, PFAS have continuously seeped into New York State's drinking water sources, agricultural soil, and aquatic ecosystems. Communities across the state have been forced to bear huge public costs for pollution monitoring, environmental restoration, and resident health screenings. This lawsuit presents several demands to the court: order all defendants to fully bear the costs of PFAS pollution control and ecological restoration statewide; force companies to add prominent risk warnings to relevant products on the market to fully inform consumers of potential hazards; and require companies to pay environmental damages, consumer compensation, and substantial civil fines to clarify corporate pollution liability through judicial channels. Global Wave of PFAS Accountability Actions; Huge Settlements Frequent in Chemical Industry New York State's lawsuit is not an isolated case. In the past two years, multiple countries and U.S. states have successively launched lawsuits against chemical companies regarding PFAS pollution. Many cases have reached settlements in the tens of billions of dollars, and the trend of industry accountability continues to escalate. Internationally, in May 2026, the Australian federal government sued 3M Company separately, accusing it of producing PFAS-containing firefighting foam that polluted 28 military bases and surrounding water and soil environments nationwide, seeking up to 2 billion Australian dollars in damages from the company. 3M responded by stating that it had stopped selling the relevant foam products long ago and that the military's long-term continuous use was the main cause of the pollution, and that it would actively defend against the claim. States within the U.S. are also intensively advancing accountability and settlement procedures: In May 2025, 3M reached a settlement with New Jersey, paying $450 million in a lump sum to resolve collective claims related to PFAS pollution from the state's factories; In August 2025, DuPont, Chemours, and Corteva, three companies with the same origin, jointly paid $2 billion to New Jersey to comprehensively resolve lawsuits related to historical PFAS pollution and ecological damage statewide; In June 2026, Chemours reached a $450 million settlement agreement with the U.S. Environmental Protection Agency (EPA) alone, addressing administrative penalty charges for its illegal discharge of PFAS into waterways over many years and locations. At the industry level, in addition to the five companies involved in this case, international chemical giants such as BASF and Solvay have also faced judicial lawsuits and regulatory penalties due to PFAS production, emissions, and product contamination issues. PFAS-related litigation has become a major compliance and financial risk point for the global chemical industry. Industry analysis points out that Chemours, Corteva, and EIDP are all historical spin-offs from DuPont. Pollution left over from DuPont's early PFAS research and production has caused the three spin-off companies to be simultaneously involved in a large number of cross-regional environmental lawsuits. The allocation of related responsibilities and sharing of compensation payments will become the focus of controversy in subsequent trials. As of the evening of July 9, the involved companies such as 3M, DuPont, and Chemours had not yet issued an official response to New York State's lawsuit. Legal experts stated that the trial period for this case may last for several years. If New York State wins the lawsuit, it will further raise compensation expectations for PFAS-related companies across the U.S., forcing the global chemical industry to accelerate the phase-out of PFAS products and the development of environmentally friendly alternative materials. Regulations in various countries regarding the production and sales control of "forever chemicals" are also expected to continue to tighten. [Copyright Notice] In the spirit of openness and inclusiveness of the Internet, ChemNet welcomes all media and institutions to reprint and quote its original content. If reprinted, please mark the source ChemNet. If you find any copyright issues with articles on this website, please contact Chemnet at [email protected]. Important information. Commodity Price chart. | Product name | Price (yuan/ton) | Price Limit | | MTBE | 6500.00 | +20.09% | | 1,3-butadiene | 10400.00 | +17.74% | | Acrylic acid | 8350.00 | +16.78% | | Propylene oxide | 9300.00 | +14.81% | | MIBK | 9300.00 | +12.05% | | Styrene | 8710.00 | +11.52% | | Crude oil | 84.23 | +10.39% | | LLDPE | 8350.00 | +10.38% | | Bisphenol A | 9260.00 | +10.37% | | Acetone | 5825.00 | +10.32% | | MEK | 7900.00 | +9.72% | | Ammonium paratungstate | 623333.31 | -9.66% | | Diethylene glycol | 9086.67 | +9.48% | | Tungsten concentrate | 420666.66 | -9.47% | | Tungsten concentrate | 421666.66 | -9.45% | Scan to access the mobile version View the latest and hottest chemical news content